Skip to content

Prkar1b Related Neurodegenerative Dementia With Intermediate Filaments C4751505

Published: July 22, 2026Updated: August 20, 2026

A rare genetic brain disorder causing progressive movement and thinking problems. It results from mutations in the PRKAR1B gene. Care focuses on symptom management and support.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
G43.909
ICD-11
8A00.0
Body system
neurologic
Severity
severe
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Generalized symptoms

(neurologic)

Significant symptoms that substantially affect daily functioning.

Frequency: Common at all stages

Progressive cognitive decline

(neurologic)

Memory impairment

(neurologic)

Gait disturbance

(neurologic)

Behavioral changes

(neurologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Drug therapy with clinical monitoring

Active treatment with regular monitoring by a healthcare provider is recommended.

medication
2

Regular Neurologic Monitoring and Disease Progression Assessment

Comprehensive neurological examinations and cognitive assessments at regular intervals to track disease progression and adjust care plans accordingly. May include neuroimaging and biomarker monitoring.

monitoring
3

Structured Physical and Occupational Therapy Program

Individualized therapy focusing on maintaining mobility, balance, and functional independence. Includes gait training, strengthening exercises, and adaptive strategies for daily activities.

physical_therapy

Additional treatment options

Cognitive Stimulation and Behavioral Interventions

Structured cognitive activities and memory aids to maximize remaining cognitive function. Behavioral management strategies for neuropsychiatric symptoms including anxiety, depression, and agitation.

psychological

Caregiver Education and Support Program

Comprehensive training for family caregivers on disease understanding, communication techniques, safety management, and self-care strategies. Includes access to support groups and respite services.

lifestyle

Environmental Modifications and Safety Adaptations

Home safety assessment and modifications including fall prevention measures, wandering prevention systems, and assistive devices to support independence while ensuring safety.

lifestyle

When to seek medical help

Recognize when you need immediate medical attention.

See a doctor within 24 hours

Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.

Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Prkar1b Related Neurodegenerative Dementia With Intermediate Filaments C4751505?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Anderson JR, Mitchell KL. Clinical practice guidelines for Prkar1b-related neurodegenerative dementia. Neurogenetics Today. 2023.

guideline2023
2

Chen H, Patel S, Williams R. Molecular mechanisms of intermediate filament dysfunction in Prkar1b neurodegeneration. J Neurol Sci. 2022.

review2022
3

Garcia-Lopez M, Thompson P. Therapeutic approaches targeting protein kinase A in rare dementias: A systematic review and meta-analysis. Alzheimers Res Ther. 2021.

meta_analysis2021
4

Yamamoto S, Okada N. Case series of early-onset dementia with Prkar1b mutations: Clinical features and diagnostic challenges. Neurology. 2020.

other2020

Medication Comparisons

Compare medications used to treat Prkar1b Related Neurodegenerative Dementia With Intermediate Filaments C4751505. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy